Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and mining markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in an environmental remediation business that manages the cleanup of redundant TEL plants. The company serves oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, formulators of personal care and home care, agrochemical and mining formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
SectorBasic Materials
Current SymbolNASDAQ:IOSP
Previous Symbol
CUSIP45768S10
Phone303-792-5554
Debt
Debt-to-Equity Ratio0.25
Current Ratio2.27
Quick Ratio1.37
Price-To-Earnings
Trailing P/E Ratio15.77
Forward P/E Ratio16.89
P/E GrowthN/A
Sales & Book Value
Annual Sales$1.31 billion
Price / Sales1.37
Cash Flow$6.8037 per share
Price / Cash10.80
Book Value$34.40 per share
Price / Book2.14
Profitability
EPS (Most Recent Fiscal Year)$4.66
Net Income$61.80 million
Net Margins4.17%
Return on Equity14.02%
Return on Assets7.88%
Miscellaneous
Employees1,900
Outstanding Shares24,420,000
Market Cap$1.80 billion
OptionableOptionable
Innospec (NASDAQ:IOSP) Frequently Asked Questions
What is Innospec's stock symbol?
Innospec trades on the NASDAQ under the ticker symbol "IOSP."
How often does Innospec pay dividends? What is the dividend yield for Innospec?
Innospec declared a semiannual dividend on Tuesday, November 6th. Shareholders of record on Monday, November 19th will be paid a dividend of $0.45 per share on Thursday, November 29th. This represents a yield of 1.18%. The ex-dividend date is Friday, November 16th. View Innospec's Dividend History.
How were Innospec's earnings last quarter?
Innospec Inc. (NASDAQ:IOSP) released its quarterly earnings data on Tuesday, November, 6th. The specialty chemicals company reported $1.20 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.06 by $0.14. The specialty chemicals company earned $363.10 million during the quarter, compared to analyst estimates of $362.50 million. Innospec had a return on equity of 14.02% and a net margin of 4.17%. Innospec's revenue for the quarter was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.00 EPS. View Innospec's Earnings History.
When is Innospec's next earnings date?
What price target have analysts set for IOSP?
2 brokers have issued 1-year price objectives for Innospec's shares. Their forecasts range from $86.00 to $86.00. On average, they anticipate Innospec's stock price to reach $86.00 in the next twelve months. This suggests a possible upside of 16.4% from the stock's current price. View Analyst Price Targets for Innospec.
What is the consensus analysts' recommendation for Innospec?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Innospec.
Has Innospec been receiving favorable news coverage?
Media stories about IOSP stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Innospec earned a news impact score of 1.7 on InfoTrie's scale. They also gave media stories about the specialty chemicals company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the near future.
Who are some of Innospec's key competitors?
Some companies that are related to Innospec include Chemours (CC), Huntsman (HUN), Ashland Global (ASH), KURARAY Co Ltd/ADR (KURRY), W. R. Grace & Co (GRA), Ingevity (NGVT), Olin (OLN), Univar (UNVR), Balchem (BCPC), PQ Group (PQG), GCP Applied Technologies (GCP), KMG Chemicals (KMG), Nexeo Solutions (NXEO), Innophos (IPHS) and Hawkins (HWKN).
Who are Innospec's key executives?
Innospec's management team includes the folowing people:
- Mr. Patrick S. Williams, Pres, CEO & Director (Age 53)
- Mr. Ian P. Cleminson, Exec. VP & CFO (Age 52)
- Dr. Philip J. Boon, COO & Exec. VP (Age 59)
- Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 69)
- Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 59)
Who are Innospec's major shareholders?
Innospec's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (16.06%), FMR LLC (14.11%), Dimensional Fund Advisors LP (6.07%), Wells Fargo & Company MN (4.76%), Huber Capital Management LLC (1.87%) and Bank of New York Mellon Corp (1.44%). Company insiders that own Innospec stock include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Joachim Roeser, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Institutional Ownership Trends for Innospec.
Which institutional investors are selling Innospec stock?
IOSP stock was sold by a variety of institutional investors in the last quarter, including Huber Capital Management LLC, FMR LLC, JPMorgan Chase & Co., JPMorgan Chase & Co., Dimensional Fund Advisors LP, Piedmont Investment Advisors Inc., ClariVest Asset Management LLC and Credit Suisse AG. Company insiders that have sold Innospec company stock in the last year include Brian Watt, Catherine Hessner, David Earl Williams, Hugh Aldous, Ian Cleminson, Ian Malcolm Mcrobbie, Milton C Blackmore, Patrick Williams, Philip Curran and Philip John Boon. View Insider Buying and Selling for Innospec.
Which institutional investors are buying Innospec stock?
IOSP stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Eagle Asset Management Inc., Wells Fargo & Company MN, Wasatch Advisors Inc., Royce & Associates LP, Bank of Montreal Can, Bank of New York Mellon Corp and Acadian Asset Management LLC. View Insider Buying and Selling for Innospec.
How do I buy shares of Innospec?
Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Innospec's stock price today?
One share of IOSP stock can currently be purchased for approximately $73.91.
How big of a company is Innospec?
Innospec has a market capitalization of $1.80 billion and generates $1.31 billion in revenue each year. The specialty chemicals company earns $61.80 million in net income (profit) each year or $4.66 on an earnings per share basis. Innospec employs 1,900 workers across the globe.
What is Innospec's official website?
How can I contact Innospec?
Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]
MarketBeat Community Rating for Innospec (NASDAQ IOSP)
MarketBeat's community ratings are surveys of what our community members think about Innospec and other stocks. Vote "Outperform" if you believe IOSP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOSP will underperform the S&P 500 over the long term. You may vote once every thirty days.
